Andrew Hull
Presidente en INMED PHARMACEUTICALS INC. .
Fortuna: 9 641 $ al 30/04/2024
Cargos activos de Andrew Hull
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INMED PHARMACEUTICALS INC. | Independent Dir/Board Member | 12/09/2016 | - |
Presidente | - | - | |
Director/Miembro de la Junta | 12/09/2016 | - |
Historial de carrera de Andrew Hull
Antiguos cargos conocidos de Andrew Hull.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Director/Miembro de la Junta | 01/03/2019 | 01/03/2020 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/06/2008 | 01/04/2018 |
Kenyon College | Director/Miembro de la Junta | - | - |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Director/Miembro de la Junta | 01/01/2009 | - |
Presidente | - | - |
Formación de Andrew Hull.
Kenyon College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Canadá | 3 |
Operativa
Director/Board Member | 4 |
Chairman | 2 |
Independent Dir/Board Member | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
INMED PHARMACEUTICALS INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Commercial Services |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Hull
- Experiencia